Overview

Probenecid as Medication for Alcohol Use Disorder

Status:
Recruiting

Trial end date:
2022-02-22

Target enrollment:

Participant gender:

Summary

The design is a randomized, within-subject, crossover, double-blind, placebo-controlled human alcohol laboratory study with one oral dose of 2g probenecid or placebo administered in two laboratory sessions.

Phase:

Phase 1

Details

Lead Sponsor:

Brown University

Treatments:

Probenecid